SlideShare uma empresa Scribd logo

Presentation Of Capabilities Elf

•Transferir como PPT, PDF•
•
Emma Lee
Emma Lee
1 de 19
Presentation of Capabilities
Capabilities ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Capabilities ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Bldg 23 Bldg 24 ‘ Border’ Facilities Penn operates from a primary site of three hectares (323,000sq.ft.) in Tredegar and a new (75,000sq.ft.) storage facility in Oakdale, South Wales. (2.5 hours west of London)
Custom Manufacture and Packing ,[object Object],[object Object],[object Object],[object Object]
Contained Manufacture Dedicated Containment Facility (DCF) ,[object Object],[object Object]
Contained Manufacture Small Scale HCO Operations ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Contained Manufacture Small Scale HCO Operations
[object Object],[object Object],[object Object],Formulation Development
[object Object],[object Object],[object Object],[object Object]
Analytical Services ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Clinical Trial Manufacture ,[object Object],[object Object],[object Object],[object Object],[object Object]
Clinical Trial Supplies ,[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Product Sourcing for CTS ,[object Object],[object Object],[object Object],[object Object],[object Object],Understanding the difference between these categories and ensuring supply chain integrity is critical for any clinical trial. Many “comparator sourcing” companies do not understand the importance of these issues.
Logistics ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
QP Services / Consulting ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Why Penn Pharma? ,[object Object],[object Object]
Contact Us ,[object Object],[object Object]

Recomendados

Nextar
NextarNextar
Nextar
shaniyerushalmy
 
Nextar presentation
Nextar presentationNextar presentation
Nextar presentation
nextar-c-s
 
Pilot plantscaleupof parentrals
Pilot plantscaleupof parentralsPilot plantscaleupof parentrals
Pilot plantscaleupof parentrals
Malla Reddy College of Pharmacy
 
Single-Use Tangential Flow Filtration for Closed Processing
Single-Use Tangential Flow Filtration for Closed ProcessingSingle-Use Tangential Flow Filtration for Closed Processing
Single-Use Tangential Flow Filtration for Closed Processing
Merck Life Sciences
 
EU GMP Annex 1 – Implications on Filtration and Single Use Technology by Soma...
EU GMP Annex 1 – Implications on Filtration and Single Use Technology by Soma...EU GMP Annex 1 – Implications on Filtration and Single Use Technology by Soma...
EU GMP Annex 1 – Implications on Filtration and Single Use Technology by Soma...
MilliporeSigma
 
EU GMP Annex 1 Draft: Implications on Sterilizing Grade Filter Validation
EU GMP Annex 1 Draft: Implications on Sterilizing Grade Filter ValidationEU GMP Annex 1 Draft: Implications on Sterilizing Grade Filter Validation
EU GMP Annex 1 Draft: Implications on Sterilizing Grade Filter Validation
MilliporeSigma
 
Sterile filtration of complex injectables by Partha Banerjee
Sterile filtration of complex injectables by Partha BanerjeeSterile filtration of complex injectables by Partha Banerjee
Sterile filtration of complex injectables by Partha Banerjee
MilliporeSigma
 
Reducing Contamination Risk and Improving Product Recovery During Final Steri...
Reducing Contamination Risk and Improving Product Recovery During Final Steri...Reducing Contamination Risk and Improving Product Recovery During Final Steri...
Reducing Contamination Risk and Improving Product Recovery During Final Steri...
Merck Life Sciences
 

Recomendados

Nextar
NextarNextar
Nextar
shaniyerushalmy
 
Nextar presentation
Nextar presentationNextar presentation
Nextar presentation
nextar-c-s
 
Pilot plantscaleupof parentrals
Pilot plantscaleupof parentralsPilot plantscaleupof parentrals
Pilot plantscaleupof parentrals
Malla Reddy College of Pharmacy
 
Single-Use Tangential Flow Filtration for Closed Processing
Single-Use Tangential Flow Filtration for Closed ProcessingSingle-Use Tangential Flow Filtration for Closed Processing
Single-Use Tangential Flow Filtration for Closed Processing
Merck Life Sciences
 
EU GMP Annex 1 – Implications on Filtration and Single Use Technology by Soma...
EU GMP Annex 1 – Implications on Filtration and Single Use Technology by Soma...EU GMP Annex 1 – Implications on Filtration and Single Use Technology by Soma...
EU GMP Annex 1 – Implications on Filtration and Single Use Technology by Soma...
MilliporeSigma
 
EU GMP Annex 1 Draft: Implications on Sterilizing Grade Filter Validation
EU GMP Annex 1 Draft: Implications on Sterilizing Grade Filter ValidationEU GMP Annex 1 Draft: Implications on Sterilizing Grade Filter Validation
EU GMP Annex 1 Draft: Implications on Sterilizing Grade Filter Validation
MilliporeSigma
 
Sterile filtration of complex injectables by Partha Banerjee
Sterile filtration of complex injectables by Partha BanerjeeSterile filtration of complex injectables by Partha Banerjee
Sterile filtration of complex injectables by Partha Banerjee
MilliporeSigma
 
Reducing Contamination Risk and Improving Product Recovery During Final Steri...
Reducing Contamination Risk and Improving Product Recovery During Final Steri...Reducing Contamination Risk and Improving Product Recovery During Final Steri...
Reducing Contamination Risk and Improving Product Recovery During Final Steri...
Merck Life Sciences
 
ADC Production - A Journey made safer and faster
ADC Production - A Journey made safer and fasterADC Production - A Journey made safer and faster
ADC Production - A Journey made safer and faster
Merck Life Sciences
 
Xcelience new
Xcelience newXcelience new
Xcelience new
anstettj
 
Xcelience New
Xcelience NewXcelience New
Xcelience New
janstett
 
The Viscosity Reduction Platform: Enabling subcutaneous (subQ) delivery
The Viscosity Reduction Platform: Enabling subcutaneous (subQ) deliveryThe Viscosity Reduction Platform: Enabling subcutaneous (subQ) delivery
The Viscosity Reduction Platform: Enabling subcutaneous (subQ) delivery
Merck Life Sciences
 
Excipients selection for high risk formulations Smita Rajput
Excipients selection for high risk formulations Smita RajputExcipients selection for high risk formulations Smita Rajput
Excipients selection for high risk formulations Smita Rajput
Merck Life Sciences
 
Reducing Contamination Risk and Improving Product Recovery During Final Steri...
Reducing Contamination Risk and Improving Product Recovery During Final Steri...Reducing Contamination Risk and Improving Product Recovery During Final Steri...
Reducing Contamination Risk and Improving Product Recovery During Final Steri...
MilliporeSigma
 
PVA for sustained release: theory and practice
PVA for sustained release: theory and practicePVA for sustained release: theory and practice
PVA for sustained release: theory and practice
MilliporeSigma
 
Parvovirus Filtration Best Practices - 25 Years of Hands-On Experience
Parvovirus Filtration Best Practices - 25 Years of Hands-On ExperienceParvovirus Filtration Best Practices - 25 Years of Hands-On Experience
Parvovirus Filtration Best Practices - 25 Years of Hands-On Experience
Merck Life Sciences
 
Pilot plant and scale up techniques
Pilot plant and scale up techniquesPilot plant and scale up techniques
Pilot plant and scale up techniques
Bhueshwar Sahu
 
Addressing handling challenges of chemicals by dry granulation
Addressing handling challenges of chemicals by dry granulationAddressing handling challenges of chemicals by dry granulation
Addressing handling challenges of chemicals by dry granulation
MilliporeSigma
 
My Industrial Training
My Industrial Training My Industrial Training
My Industrial Training
Abhishek Mishra
 
Potential Impact of Draft Annex 1 on Sterilizing Filtration
Potential Impact of Draft Annex 1 on Sterilizing FiltrationPotential Impact of Draft Annex 1 on Sterilizing Filtration
Potential Impact of Draft Annex 1 on Sterilizing Filtration
MilliporeSigma
 
Pilot plant scale up for parentrals
Pilot plant scale up for parentralsPilot plant scale up for parentrals
Pilot plant scale up for parentrals
Parag Behura
 
Formulation Development Services
Formulation Development ServicesFormulation Development Services
Formulation Development Services
Kemwell Biopharma
 
Addressing Downstream Challenges with Complex Injectables
Addressing Downstream Challenges with Complex InjectablesAddressing Downstream Challenges with Complex Injectables
Addressing Downstream Challenges with Complex Injectables
Merck Life Sciences
 
When Coating runs smoothly: Enhance your Coating Process with a new Particle ...
When Coating runs smoothly: Enhance your Coating Process with a new Particle ...When Coating runs smoothly: Enhance your Coating Process with a new Particle ...
When Coating runs smoothly: Enhance your Coating Process with a new Particle ...
Merck Life Sciences
 
Using Single-use Technology to Overcome the Challenges of ADC Processing
Using Single-use Technology to Overcome the Challenges of ADC ProcessingUsing Single-use Technology to Overcome the Challenges of ADC Processing
Using Single-use Technology to Overcome the Challenges of ADC Processing
Merck Life Sciences
 
Hot melt extrusion with PVA – solubility enhancement, supersaturation perform...
Hot melt extrusion with PVA – solubility enhancement, supersaturation perform...Hot melt extrusion with PVA – solubility enhancement, supersaturation perform...
Hot melt extrusion with PVA – solubility enhancement, supersaturation perform...
Merck Life Sciences
 
Pilot plant scale up for Small Volume Parenterals
Pilot plant scale up for Small Volume Parenterals Pilot plant scale up for Small Volume Parenterals
Pilot plant scale up for Small Volume Parenterals
Dr. Prashant L. Pingale GES's Sir Dr. M. S. Gosavi College of Pharmacy, Nashik
 
Hot melt extrusion with PVA: A new opportunity for challenging APIs
Hot melt extrusion with PVA: A new opportunity for challenging APIs Hot melt extrusion with PVA: A new opportunity for challenging APIs
Hot melt extrusion with PVA: A new opportunity for challenging APIs
Merck Life Sciences
 
Layout of Tablet Manufacturing Section
Layout of Tablet Manufacturing Section Layout of Tablet Manufacturing Section
Layout of Tablet Manufacturing Section
Nitin Kadam
 
Company profile nirman conlatest -2
Company profile nirman conlatest -2Company profile nirman conlatest -2
Company profile nirman conlatest -2
nirmanconstructions
 

Mais conteúdo relacionado

Mais procurados

ADC Production - A Journey made safer and faster
ADC Production - A Journey made safer and fasterADC Production - A Journey made safer and faster
ADC Production - A Journey made safer and faster
Merck Life Sciences
 
Excipients selection for high risk formulations Smita Rajput
Excipients selection for high risk formulations Smita RajputExcipients selection for high risk formulations Smita Rajput
Excipients selection for high risk formulations Smita Rajput
Merck Life Sciences
 
Reducing Contamination Risk and Improving Product Recovery During Final Steri...
Reducing Contamination Risk and Improving Product Recovery During Final Steri...Reducing Contamination Risk and Improving Product Recovery During Final Steri...
Reducing Contamination Risk and Improving Product Recovery During Final Steri...
MilliporeSigma
 
PVA for sustained release: theory and practice
PVA for sustained release: theory and practicePVA for sustained release: theory and practice
PVA for sustained release: theory and practice
MilliporeSigma
 
When Coating runs smoothly: Enhance your Coating Process with a new Particle ...
When Coating runs smoothly: Enhance your Coating Process with a new Particle ...When Coating runs smoothly: Enhance your Coating Process with a new Particle ...
When Coating runs smoothly: Enhance your Coating Process with a new Particle ...
Merck Life Sciences
 
Hot melt extrusion with PVA – solubility enhancement, supersaturation perform...
Hot melt extrusion with PVA – solubility enhancement, supersaturation perform...Hot melt extrusion with PVA – solubility enhancement, supersaturation perform...
Hot melt extrusion with PVA – solubility enhancement, supersaturation perform...
Merck Life Sciences
 
Hot melt extrusion with PVA: A new opportunity for challenging APIs
Hot melt extrusion with PVA: A new opportunity for challenging APIs Hot melt extrusion with PVA: A new opportunity for challenging APIs
Hot melt extrusion with PVA: A new opportunity for challenging APIs
Merck Life Sciences
 

Mais procurados (20)

ADC Production - A Journey made safer and faster
ADC Production - A Journey made safer and fasterADC Production - A Journey made safer and faster
ADC Production - A Journey made safer and faster
 
Xcelience new
Xcelience newXcelience new
Xcelience new
 
Xcelience New
Xcelience NewXcelience New
Xcelience New
 
The Viscosity Reduction Platform: Enabling subcutaneous (subQ) delivery
The Viscosity Reduction Platform: Enabling subcutaneous (subQ) deliveryThe Viscosity Reduction Platform: Enabling subcutaneous (subQ) delivery
The Viscosity Reduction Platform: Enabling subcutaneous (subQ) delivery
 
Excipients selection for high risk formulations Smita Rajput
Excipients selection for high risk formulations Smita RajputExcipients selection for high risk formulations Smita Rajput
Excipients selection for high risk formulations Smita Rajput
 
Reducing Contamination Risk and Improving Product Recovery During Final Steri...
Reducing Contamination Risk and Improving Product Recovery During Final Steri...Reducing Contamination Risk and Improving Product Recovery During Final Steri...
Reducing Contamination Risk and Improving Product Recovery During Final Steri...
 
PVA for sustained release: theory and practice
PVA for sustained release: theory and practicePVA for sustained release: theory and practice
PVA for sustained release: theory and practice
 
Parvovirus Filtration Best Practices - 25 Years of Hands-On Experience
Parvovirus Filtration Best Practices - 25 Years of Hands-On ExperienceParvovirus Filtration Best Practices - 25 Years of Hands-On Experience
Parvovirus Filtration Best Practices - 25 Years of Hands-On Experience
 
Pilot plant and scale up techniques
Pilot plant and scale up techniquesPilot plant and scale up techniques
Pilot plant and scale up techniques
 
Addressing handling challenges of chemicals by dry granulation
Addressing handling challenges of chemicals by dry granulationAddressing handling challenges of chemicals by dry granulation
Addressing handling challenges of chemicals by dry granulation
 
My Industrial Training
My Industrial Training My Industrial Training
My Industrial Training
 
Potential Impact of Draft Annex 1 on Sterilizing Filtration
Potential Impact of Draft Annex 1 on Sterilizing FiltrationPotential Impact of Draft Annex 1 on Sterilizing Filtration
Potential Impact of Draft Annex 1 on Sterilizing Filtration
 
Pilot plant scale up for parentrals
Pilot plant scale up for parentralsPilot plant scale up for parentrals
Pilot plant scale up for parentrals
 
Formulation Development Services
Formulation Development ServicesFormulation Development Services
Formulation Development Services
 
Addressing Downstream Challenges with Complex Injectables
Addressing Downstream Challenges with Complex InjectablesAddressing Downstream Challenges with Complex Injectables
Addressing Downstream Challenges with Complex Injectables
 
When Coating runs smoothly: Enhance your Coating Process with a new Particle ...
When Coating runs smoothly: Enhance your Coating Process with a new Particle ...When Coating runs smoothly: Enhance your Coating Process with a new Particle ...
When Coating runs smoothly: Enhance your Coating Process with a new Particle ...
 
Using Single-use Technology to Overcome the Challenges of ADC Processing
Using Single-use Technology to Overcome the Challenges of ADC ProcessingUsing Single-use Technology to Overcome the Challenges of ADC Processing
Using Single-use Technology to Overcome the Challenges of ADC Processing
 
Hot melt extrusion with PVA – solubility enhancement, supersaturation perform...
Hot melt extrusion with PVA – solubility enhancement, supersaturation perform...Hot melt extrusion with PVA – solubility enhancement, supersaturation perform...
Hot melt extrusion with PVA – solubility enhancement, supersaturation perform...
 
Pilot plant scale up for Small Volume Parenterals
Pilot plant scale up for Small Volume Parenterals Pilot plant scale up for Small Volume Parenterals
Pilot plant scale up for Small Volume Parenterals
 
Hot melt extrusion with PVA: A new opportunity for challenging APIs
Hot melt extrusion with PVA: A new opportunity for challenging APIs Hot melt extrusion with PVA: A new opportunity for challenging APIs
Hot melt extrusion with PVA: A new opportunity for challenging APIs
 

Destaque

Layout of Tablet Manufacturing Section
Layout of Tablet Manufacturing Section Layout of Tablet Manufacturing Section
Layout of Tablet Manufacturing Section
Nitin Kadam
 
Facility requirements for Hazardous drug Manufacturing
Facility requirements for Hazardous drug ManufacturingFacility requirements for Hazardous drug Manufacturing
Facility requirements for Hazardous drug Manufacturing
ehab mohamed
 
Pilot plant scale up techniques for solid dosage forms
Pilot plant scale up techniques for solid dosage formsPilot plant scale up techniques for solid dosage forms
Pilot plant scale up techniques for solid dosage forms
ElahehEntezarmahdi
 
Batch Expiration Date Management in SAP MRP/MPS
Batch Expiration Date Management in SAP MRP/MPS Batch Expiration Date Management in SAP MRP/MPS
Batch Expiration Date Management in SAP MRP/MPS
Vijay Pisipaty
 
Pilot plant scale up for tablets
Pilot plant scale up for tabletsPilot plant scale up for tablets
Pilot plant scale up for tablets
Robin Gulati
 

Destaque (20)

Layout of Tablet Manufacturing Section
Layout of Tablet Manufacturing Section Layout of Tablet Manufacturing Section
Layout of Tablet Manufacturing Section
 
Company profile nirman conlatest -2
Company profile nirman conlatest -2Company profile nirman conlatest -2
Company profile nirman conlatest -2
 
Attributes of Magesium Stearate as a Tablet Lubricant
Attributes of Magesium Stearate as a Tablet LubricantAttributes of Magesium Stearate as a Tablet Lubricant
Attributes of Magesium Stearate as a Tablet Lubricant
 
Alkermes high potency whitepaper 2014
Alkermes high potency whitepaper 2014Alkermes high potency whitepaper 2014
Alkermes high potency whitepaper 2014
 
Fluidized bed dryers
Fluidized bed dryersFluidized bed dryers
Fluidized bed dryers
 
Pilot plant tablets
Pilot plant tabletsPilot plant tablets
Pilot plant tablets
 
Facility requirements for Hazardous drug Manufacturing
Facility requirements for Hazardous drug ManufacturingFacility requirements for Hazardous drug Manufacturing
Facility requirements for Hazardous drug Manufacturing
 
Effervescent Tablets
Effervescent TabletsEffervescent Tablets
Effervescent Tablets
 
Double cone blender
Double cone blenderDouble cone blender
Double cone blender
 
Pilot plant scale up techniques for solid dosage forms
Pilot plant scale up techniques for solid dosage formsPilot plant scale up techniques for solid dosage forms
Pilot plant scale up techniques for solid dosage forms
 
Batch Expiration Date Management in SAP MRP/MPS
Batch Expiration Date Management in SAP MRP/MPS Batch Expiration Date Management in SAP MRP/MPS
Batch Expiration Date Management in SAP MRP/MPS
 
Alkermes high potency capabilities
Alkermes high potency capabilities Alkermes high potency capabilities
Alkermes high potency capabilities
 
Pilot plant scale up for tablets
Pilot plant scale up for tabletsPilot plant scale up for tablets
Pilot plant scale up for tablets
 
Pilot plant design for tablets and capsules
Pilot plant design for tablets and capsulesPilot plant design for tablets and capsules
Pilot plant design for tablets and capsules
 
Anthony crasto scaleup techniques & pilot plant
Anthony crasto scaleup techniques & pilot plantAnthony crasto scaleup techniques & pilot plant
Anthony crasto scaleup techniques & pilot plant
 
SAP PP MRP Guide for Beginners
SAP PP MRP Guide for BeginnersSAP PP MRP Guide for Beginners
SAP PP MRP Guide for Beginners
 
Sap MRP materials requirements planning
Sap MRP materials requirements planningSap MRP materials requirements planning
Sap MRP materials requirements planning
 
Pharmaceutical process scale up
Pharmaceutical process scale upPharmaceutical process scale up
Pharmaceutical process scale up
 
Validation Of Solid Dosage Forms.
Validation Of Solid Dosage Forms.Validation Of Solid Dosage Forms.
Validation Of Solid Dosage Forms.
 
Tablet manufacturing process created by Asadulla Mulla
Tablet manufacturing process created by Asadulla MullaTablet manufacturing process created by Asadulla Mulla
Tablet manufacturing process created by Asadulla Mulla
 

Semelhante a Presentation Of Capabilities Elf

Core Rx Presentation
Core Rx PresentationCore Rx Presentation
Core Rx Presentation
marklicarde_1
 
Sitec Presentation 140915
Sitec Presentation 140915Sitec Presentation 140915
Sitec Presentation 140915
Sitec Labs
 
Vergo - Corporate presentation-3 June 2016
Vergo - Corporate presentation-3 June 2016Vergo - Corporate presentation-3 June 2016
Vergo - Corporate presentation-3 June 2016
Aniket Manathkar
 
Enem Nostrum Presentation
Enem Nostrum PresentationEnem Nostrum Presentation
Enem Nostrum Presentation
Amit Khandagale
 
Optimize Your Process Validation Package
Optimize Your Process Validation PackageOptimize Your Process Validation Package
Optimize Your Process Validation Package
Merck Life Sciences
 
Kuecept Corporate Presentation 2014
Kuecept Corporate Presentation 2014 Kuecept Corporate Presentation 2014
Kuecept Corporate Presentation 2014
Mark Saunders
 
INDUSTRIAL TRAINING REPORT (B-pharmacy ) Zentiva pharmaceutical industry
INDUSTRIAL TRAINING REPORT (B-pharmacy ) Zentiva pharmaceutical industry INDUSTRIAL TRAINING REPORT (B-pharmacy ) Zentiva pharmaceutical industry
INDUSTRIAL TRAINING REPORT (B-pharmacy ) Zentiva pharmaceutical industry
PrakashKumar721
 
Biodextris Presentation - New client presentation
Biodextris Presentation - New client presentationBiodextris Presentation - New client presentation
Biodextris Presentation - New client presentation
Joseph Zimmermann
 

Semelhante a Presentation Of Capabilities Elf (20)

CoreRx presentation
CoreRx presentationCoreRx presentation
CoreRx presentation
 
High Quality Integrated Drug R&D Services
High Quality Integrated Drug R&D ServicesHigh Quality Integrated Drug R&D Services
High Quality Integrated Drug R&D Services
 
PharmaSynth Biopharmaceutical Manufacturing Services
PharmaSynth Biopharmaceutical Manufacturing ServicesPharmaSynth Biopharmaceutical Manufacturing Services
PharmaSynth Biopharmaceutical Manufacturing Services
 
Core Rx Presentation
Core Rx PresentationCore Rx Presentation
Core Rx Presentation
 
Core Rx Presentation
Core Rx PresentationCore Rx Presentation
Core Rx Presentation
 
Sitec Presentation 140915
Sitec Presentation 140915Sitec Presentation 140915
Sitec Presentation 140915
 
What format is best for your laboratory
What format is best for your laboratoryWhat format is best for your laboratory
What format is best for your laboratory
 
Diteba Research Laboratories Corporate Capabilities
Diteba Research Laboratories Corporate CapabilitiesDiteba Research Laboratories Corporate Capabilities
Diteba Research Laboratories Corporate Capabilities
 
Vergo - Corporate presentation-3 June 2016
Vergo - Corporate presentation-3 June 2016Vergo - Corporate presentation-3 June 2016
Vergo - Corporate presentation-3 June 2016
 
Apresentação cipan sbe ist_2016_4(post link_in)
Apresentação cipan sbe ist_2016_4(post link_in)Apresentação cipan sbe ist_2016_4(post link_in)
Apresentação cipan sbe ist_2016_4(post link_in)
 
Pyramid Laboratories Overview
Pyramid Laboratories OverviewPyramid Laboratories Overview
Pyramid Laboratories Overview
 
Enem Nostrum Presentation
Enem Nostrum PresentationEnem Nostrum Presentation
Enem Nostrum Presentation
 
Internship training report on Dr. Milton Laboratories Pvt. Ltd..docx
Internship training report on Dr. Milton Laboratories Pvt. Ltd..docxInternship training report on Dr. Milton Laboratories Pvt. Ltd..docx
Internship training report on Dr. Milton Laboratories Pvt. Ltd..docx
 
DCN Company Profile 2015
DCN Company Profile 2015DCN Company Profile 2015
DCN Company Profile 2015
 
Optimize Your Process Validation Package
Optimize Your Process Validation PackageOptimize Your Process Validation Package
Optimize Your Process Validation Package
 
Kuecept Corporate Presentation 2014
Kuecept Corporate Presentation 2014 Kuecept Corporate Presentation 2014
Kuecept Corporate Presentation 2014
 
MDC Connects Series 2021 | A Guide to Complex Medicines: Overcoming the Chall...
MDC Connects Series 2021 | A Guide to Complex Medicines: Overcoming the Chall...MDC Connects Series 2021 | A Guide to Complex Medicines: Overcoming the Chall...
MDC Connects Series 2021 | A Guide to Complex Medicines: Overcoming the Chall...
 
Pharmaceutical Product development technology
Pharmaceutical Product development technologyPharmaceutical Product development technology
Pharmaceutical Product development technology
 
INDUSTRIAL TRAINING REPORT (B-pharmacy ) Zentiva pharmaceutical industry
INDUSTRIAL TRAINING REPORT (B-pharmacy ) Zentiva pharmaceutical industry INDUSTRIAL TRAINING REPORT (B-pharmacy ) Zentiva pharmaceutical industry
INDUSTRIAL TRAINING REPORT (B-pharmacy ) Zentiva pharmaceutical industry
 
Biodextris Presentation - New client presentation
Biodextris Presentation - New client presentationBiodextris Presentation - New client presentation
Biodextris Presentation - New client presentation
 

Presentation Of Capabilities Elf

  • 2.
  • 3.
  • 4. Bldg 23 Bldg 24 ‘ Border’ Facilities Penn operates from a primary site of three hectares (323,000sq.ft.) in Tredegar and a new (75,000sq.ft.) storage facility in Oakdale, South Wales. (2.5 hours west of London)
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.